Skip to main content

Table 1 Evaluation of H1.3 immunohistochemistry [18]

From: Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Immunoreactivity

 

H1.3 + cells

0

0–4%

1

5–24%

2

25–49%

3

50–100%

Intensity

0

negative

1

mild

2

intermediate

3

intense